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Abstract.  The host range of Trypanosoma  brucei 
brucei is restricted by the cytolytic effects of human 
serum high-density  lipoprotein  (HDL).  The lyric activ- 
ity is caused by a  minor  subclass of human  serum 
HDL called trypanosome lytic factor (TLF).  TLF 
binds in the flagellar pocket to specific TLF-binding 
sites.  Internalization  and localization  of TLF to a 
population  of endocytic vesicles, and ultimately  large 
lysosome-like vesicles, precedes lysis of Z  b.  brucei. 
The membranes  of these large vesicles are disrupted 
by the accumulation  of TLF particles.  Inhibitor  studies 
with lysosomotropic amines have shown these large 
vesicles to be acidic in nature and that prevention of 
their rupture  spares the cells from TLF-mediated  lysis. 
Furthermore,  leupeptin  inhibition  suggests that a 
thioprotease  may be involved in the mechanism  of 
TLF-mediated lysis of T.  b.  brucei. Based on these 
results,  we propose a  lyric mechanism  involving  cell 
surface binding,  endocytosis and lysosomal targeting. 
This  is followed by lysosomal disruption  and subse- 
quent autodigestion of the cell. 
T  RYPANOSOMES  are the causative agents of both human 
and  cattle  diseases  in  large  regions  of sub-Saharan 
Africa  (8).  Z  b.  gambiense  and  Z  b.  rhodesiense 
cause the chronic and acute forms of human sleeping sick- 
ness. T. b. brucei causes the cattle disease, nagana, but is un- 
able to infect humans (16,  17,  19). The three subspecies of 
T.  brucei are biochemically and morphologically  indistin- 
guishable and are defined by human infectivity or sensitivity 
to normal human serum in vitro (27). Early work by Rifldn 
(28) identified the cytolytic component of human serum as 
a  high-density  lipoprotein  (HDL) ~.  A  number  of recent 
studies  support  the  role of human  HDL in  the killing  of 
T. b. brucei. HDL is now widely accepted as being a major 
factor in preventing the infection of humans by T. b. brucei 
(11, 13,  15, 28). 
The nature of the cytotoxic HDL particles is more con- 
1. Abbreviations  used in this paper: HDL, high density lipoprotein; HPLC, 
high pressure liquid chromatography; LDL, low density lipoprotein; TLF, 
trypanosome lyric factor. 
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troversial, due to the heterogeneity of human serum HDLs. 
Human serum HDLs vary in size, apolipoprotein, and lipid 
content (10).  In addition,  a number of enzymatic activities 
have been found to be associated with specific subclasses of 
HDL (20, 25). In Rifkin's initial study, the lyric activity over- 
lapped but did not coincide with HDL, suggesting that the 
lyric activity might  be a  subclass of HDL particles  (28). 
Gillett and Owen (11, 13, 24) have reported that all human 
serum  HDLs  are  lyric  and  that  the  active  component  is 
apolipoprotein A-I. On the other hand, we found the toxicity 
of human HDL for T. b. brucei was not a general feature of 
all human  serum HDL but was restricted to a minor sub- 
population of HDL particles of very high density (p =  1.24 
g/ml) and unusually large size (20-nm diam) (15, 17).  This 
trypanolytic subclass of human serum HDL has been named 
trypanosome lyric factor (TLF).  In addition to the typical 
HDL associated apolipoproteins A-I and A-II, two unique 
apolipoproteins,  L-I (94,500 D) and L-Ill (49,500 D) (15, 
17) are also constituents of TLF (see Materials and Meth- 
ods). These studies showed trypanosome lyric activity was 
limited to a subpopulation of human HDLs, supporting the 
earlier work of Rifkin (28). 
Other host macromolecules have also been shown to inter- 
act with the trypanosome.  The most striking examples are 
the studies on the binding and uptake of transferrin  (2, 33) 
and low density lipoprotein (LDL) (7) by bloodstream try- 
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fin are taken up by receptor-mediated endocytosis. It is now 
clear  endocytosis  only  occurs  at  the  flageUar  pocket  of 
trypanosomes. Binding studies indicate that LDL and trans- 
ferrin bind to the flagellum and the flagellar pocket and are 
endocytosed  via coated pits and vesicles  which ultimately 
fuse with degradarive organelles  (lysosomes?). 
Several mechanisms have been proposed to explain the ly- 
sis of T. b. brucei by human serum (13, 30, 31). The simplest 
requires specific binding of TLF to T. b.  brucei.  In this re- 
port we show TLF binds specifically  to the flagellar pocket 
membrane of T. b. brucei. Electron and fluorescence micros- 
copy reveal that TLF is endocytosed and a series of inhibitor 
studies  with  lysosomotropic  amines  verify  the role  of en- 
docytosis in the lyric pathway.  Finally, we used a variety of 
techniques  showing  localization  of  endocytosed  TLF  to 
lysosome-like  vesicles  and demonstrating the essential  na- 
ture of vesicle breakdown in the lyric pathway. 
Materials and Methods 
Cell Culture and Lysis Assay 
A clonal line of Z  b. brucei, ILTat 1.3, was used in all experiments. ILTat 
1.3 is an antigenically stable cell line which produces acute, monomorphic 
infections in laboratory rodents. Trypanosomes were grown to 1-5  ×  l0  s 
cells/m] in Swiss CD-1 mice and harvested using a protocol modified from 
Lanham (22). Briefly,  cells are harvested either by cardiac puncture or a 
post vena cava puncture and diluted with an equal volume of 4°C bicine 
buffer (50 mM bicine at pH 8.0, 70 mM glucose, 5 mM KC1, and 50 mM 
NaC1) supplemented with 100 U/m] heparin (1). Cells are separated from 
the  blood  by  passing  over  a  DEAE-cellulose  column  (22)  previously 
equilibrated in bicine buffer. Trypanosomes are washed and resuspended to 
a final cell density of 3  ×  10T/m] in F-12 medium (GIBCO BRL, Galthers- 
burg, MD), containing 15 % (vol/vol) fetal bovine serum (heat-inactivated), 
1% (wt/vol) glucose, 30 mM Hepes (pH 7.4).  Lysis assays carried out as 
previously described (15).  Inhibitor lysis assays were performed as de- 
scribed (15) with the exception of a pre incubation period of 30 min at 4°C 
with either ammonium chloride (1 to 32 mM), chloroquine (0.25  to  100 
aM), or monensin (0.01 to 0.1 ~,M). Higher concentrations of these weak 
basic amines (364 mM for NI-hC1 and 3300/tM for chloroquine), were 
toxic to the trypanosomes. Higher concentrations (31.0 ~,M) of monensin 
were also lethal to trypanosomes. The cells were then shifted to 37°C and 
treated with TLF for 2 h. In the case of the protease inhibitor studies, cells 
were pre-incubated with 0.01 mM to 1.0 mM leupeptin for 1 h at 37°C and 
subsequently treated for an additional 2 h at 37°C with TLF. All inhibitors 
were made fresh the day of assay and dissolved in PBS/EDTA phosphate 
buffered saline. Inhibitors were supplied from Sigma Chemical Co.  (St. 
Louis,  MO)  except monensin  which  was  obtained  from  Calbiochem- 
Behring Corp. (Palo Alto, CA). Monensin was dissolved in DMSO and in- 
soluble particulates were spun out before use. 
Serum Lipoprotein and TLF Purification 
Normal human blood was obtained from healthy, fasted donors and LDL, 
non-lyric HDL, and TLF were purified as described previously (15). Typi- 
cally, "o500/tg of highly purified TLF (10,000-20,000  U) was recovered 
from 200 m] of human serum. Non-lyric HDL (p -- 1.063-1.17 g/m]) and 
LDL (p =  1.002-1.063  g/m]) were also prepared by sodium bromide flota- 
tion and were dialyzed against PBS-EDTA prior to use. 
Characterization of  Purified TLF 
SDS-PAGE of 125I-TLF and autoradiography (Fig.  1) indicated that each 
TLF  associated protein labeled  with  125I in  proportion to  the relative 
amount of staining by Coomassie blue (data not shown). Apolipoproteins 
A-I and A-II were identified based on reactivity with monospecific poly- 
clonal and monoclonal antibodies (data not shown) and apparent molecular 
weights estimated under nonreducing and reducing conditions. Two addi- 
tional proteins are enriched in purified TLF preparations. The 94,500 D 
Figure 1.  125I-labeling of TLF 
apolipoproteins  (see  Materi- 
als  and  Methods).  TLF  was 
purified  and  t25I labeled  as 
described  in  Materials  and 
Methods.  Autoradiogram  of 
apolipoproteins  separated  on 
12 %  SDS-polyacrylamide 
gels containing 4  M  urea un- 
der  reducing  (R)  and  nonre- 
ducing  (NR)  conditions.  The 
size of  the apo L-I (94,500 D), 
apo L-III (45,500 D), apo A-I 
(28000 D), and apo A-II dimer 
(17,000 D) was estimated rela- 
tive to protein standards (Sigma 
Chemical Co.). 
(ape L-I) and 49,500 D (apo L-m) proteins were previously referred to as 
"band a" and ~band c" (15). To be more consistent with established nomen- 
clature and to avoid confusion with apolipoproteins A-I and A-If we have 
adopted this new nomenclature (17). The previously reported "band b", seen 
in earlier preparations, was absent in more highly purified TLF prepara- 
tions. The protein which runs at '°65,000 D is human serum albumin. For 
comparison we also radioiodinated non-lyric human HDL (p =  1.063-1.17 
g/m]). The major structural apolipoproteins A-I (28,016 D) and A-II (8,500 
D) were seen under reducing conditions while the A-II dimer (17,000 D) 
is seen under nonreducing conditions (data not shown). L-I and L-HI were 
not detected in  these preparations  since TLF  represents <0.5%  of the 
total HDL. 
Binding Studies 
To examine the binding of serum high density lipoproteins to T. b.  brucei, 
purified TLF and non-lyric HDUs were radioiodinated. TLF and HDL were 
radiolabeled according to a modified method of Goldstein et al. (14). The 
reaction was carried out in a solution of PBS/EDTA and 78 mM Tris base 
(pH 9.9).  The catalyst used was Iodogen (1,  3,  4,  6-tetrachloro- 3  ~, 6 
.-diphe~ylgly~-~)  (Sigma Chemi~ Co.). Sodium ~25I  00 ~,C~g protein) 
was added to purified TLF or HDL and incubated at 26°C for 15 rain. Unin- 
corporated 125I was removed by dialysis against PBS/EDTA or by filtration 
on a PD10 column (Pharmacia Fine Chemicals, Piscataway,  NJ). Less than 
5 % of  the 125I radioactivity was extractable into chloroform-methanol (14). 
Specific activities of ~0-5,000 cpm/ng of TLF or HDL protein were ob- 
tained.  SDS-polyacrylamide and  autorndiography of 125I-TLF and  125I- 
HDL were used to verify the labeling of the apolipoproteins. For binding 
studies, Z  b. brucei was grown to 1-5  x  l0  s cells/m] in Swiss CD-1 mice 
and harvested as discussed above. The cells were washed with F-12/BSA 
buffer (F-12 media,  1% [wt/vol] bovine serum albumin,  1%  [wt/vol] glu- 
cose, 30 mM Hepes [pH 7.4]).  Binding studies were carried out for 1 h at 
4°C in the same buffer at a  final cell density of 1  x  107/ml.  Following 
binding, cells were washed three times with PBS/EDTA (pH 7.4),  cen- 
trifuged at 4°C at 6,000 rpm in a microfuge, and counted immediately. The 
specificity of TLF was established by competition studies. In these studies, 
Z  brucei was incubated for I h at 4°C with 5 ~,g/m] 125I-TLF and no com- 
petitor or with a  10-fold mass excess of unlabeled TLF,  non-lyric HDL, 
LDL, or IL1ht  1.3 VSG. The number of TLF binding sites was based on 
the half-maximal binding and an estimated molecular weight of 5  ×  105 
for TLF (15). 
Fluorescence Microscopy 
Fluorescent studies were carried out in F-12/BSA buffer. The cells were in- 
cubated (at a final cell density of 1 ×  10T/m]) with inhibitors as described 
in  the lysis  assay  above.  The  optimal  inhibitor  concentrations  for  the 
fluorescent studies were determined from the inhibitor lysis assays. The 
concentrations used were  8  mM  NI-hCI,  50  /~M  cMoroquine, 0.6  mM 
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Figure 2. Binding of 12SI-TLF  and ~25I-HDL to T. b. brucei. Bind- 
ing studies were carried-out as described in Materials and Methods. 
(A) Concentration dependence of TLF binding. TLF concentration 
is expressed as #g/rnl. Trypanosomes were incubated at 4°C for I h 
with  varying concentrations of 12SI-TLE washed,  and  counted. 
Each point is the average of  three binding experiments. (B) Concen- 
tration dependence of  HDL binding (expressed as/zg/ml). Trypano- 
somes were  incubated at 4°C  for  1 h  with varying concentra- 
tions of non-lytic ~2~I-HDL (33-700/~g/ral), washed, and counted. 
(C) Competition of high and low affinity TLF binding with non- 
lyric HDL. The competition for TLF binding was examined at con- 
centrations ranging from 3 to 40 #g/ml in the presence of a constant 
mass excess (300/zg) of non-lytic HDL. The black filled  dots repre- 
sent the amounts of TLF binding at different TLF concentrations. 
The white filled dots represent the amount of TLF binding in the 
presence of competitor (a fixed amount of non-lytic HDL competi- 
tor at a concentration of 1,000/zg/ml). 
leupeptin, and 0.1  /~M monensin. The cells were then incubated with 3 
mg/ml of tetrarnethylrhodamine-labeled dextran (Molecular Probes, Eu- 
gene, OR; Mr =  10,000;  neutral charge) for 30 rain at 37"C. Dextran is 
a bulk phase endocytie marker used to fluorescenfly monitor endocytic vesi- 
cle integrity. Sample cells were subsequently treated with 4 U of TLF for 
45 min at 37"C, control cells were mock treated at same time and tempera- 
ture. The ceils were fixed in EM grade 1% final concentration formaldehyde 
(Toumisin Res. Corp., Rockville, MD), washed three times with 0.37 % EM 
grade formaldehyde and resuspended in '~100 t~l of  0.37% EM grade form- 
aldehyde. One third of the cell suspension was mounted onto slides (by 
cytospinning the sample onto the slide), stained with 20/~g/ml Hoescht dye 
and treated with a modified mountant to inhibit fading. The motmtant was 
in 1:9 PBS/glycerol containing 0.1% phenylene diamine (Fisher Scientific 
Co., Pittsburgh, PA). 
Image Acquisition 
The slide specimens were viewed using a Leitz fluorescence microscope 
equipped with a Vario Orthomat II camera system. The magnification fac- 
tors include: 100x oil immersion lens, zoom of 9.7, tube length of 1.25x, 
and camera lens magnification of 0.32x.  Cells were photographed using 
Kodak Ektachrome (EES 135-6) 800/1600 film (pushed to 1600 ASA in the 
development). 
Electron Microscopy 
TLF was conjugated to colloidal gold as described by Handle), et al. (18). 
Conjugation reactions were verified by negative staining with 2 % (wt/vol) 
sodium phosphotungstate (pH 5.9) and examination with a Zeiss 10 electron 
microscope. In order to study the localization of TLF binding, cells were 
prepared for transmission electron microscopy following incubation with 
TLF-gold complexes (6.7 t~g/rnl at 4°C for 1 h). Cells were washed exten- 
sively in PBS-EDTA at 4"C to remove unbound TLF gold complexes. Sam- 
ples were then fixed with 2 % (vol/vol) glutaraldehyde and postfixed in 1% 
(wt/vol) osmium tetroxide in 0.1 M sodium phosphate buffer (pH 7.5) con- 
taining 4% (wt/vol) sucrose. The uptake of  TLF at higher temperatures was 
studied by first binding TLF to the cells at 4"C as described above. After 
removing unbound TLE the cells were shifted to the higher temperatures. 
The distribution of TLF-gold complexes was determined by examination of 
>200 cells from samples incubated at 4 °, 17 % and 37"C. The number of 
TLF-gold particles were counted in sections through the FP, SV and tubules 
adjacent to the flagellar pocket, and LV or free in the cytoplasm. 
Results 
TLF Binding to T. B. brucei 
Killing of trypanosomes by human serum or HDL involves 
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Figure 3. Inhibition of TLF-mediated lysis of T. b. brucei by heat- 
inactivated TLF and non-lyric HDL. Non-lyric human serum HDL 
(5, 50, and 100 #g) or heat-inactivated  TLF (2, 4, 6, and 10 U) was 
incubated with 2 U of active TLF (,00.5/zg protein) and the lysis 
of T. b. brucei was determined following standard assay conditions 
(Materials and Methods). TLF was inactivated by thermal denatu- 
ration at 90°C for 15 min. 
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The Journal of Cell Biology, Volume  126, 1994  158 Figure 4. Localization of TLF binding at 4°C to T. b. brucei. TLF was conjugated to colloidal gold as described (18). Cells were incubated 
with the TLF-gold complexes at a concentration of approximately 6.7/zg/ml. (A) Negative staining of TLF-gold complexes. Complexes 
were stained with sodium phosphotungstate, collected on formvar coated grids and examined by transmission electron microscopy. (B) 
Thin section electron micrograph of Z  b.  brucei incubated at 4°C for 1 h with TLF-gold complexes. TLF-gold complexes bound to the 
flagellar pocket (FP) membrane. (C) Thin section electron micrograph of Z  b. brucei incubated at 4°C with TLF-gold complexes. Binding 
is seen both in the flagellar pocket and to the junction region at the flagellum (F,, arrow). (D) Thin section electron micrograph of a dividing 
Z  b. brucei with TLF-gold complexes in both flagellar pockets (FP). (E) Thin section electron mierograph of TLF-gold complexes bound 
to the junction region (bracket) and to the flagella (F,, arrow).  (F) Thin section electron micrograph of TLF-gold complexes bound to 
the flagella pocket membrane. One of the complexes is associated with a small ~pit" in the flagellar pocket membrane (arrow). (G) Thin 
section electron micrograph of TLF-gold complexes associated with flagellar pocket "pits" (arrow).  Bar, 0.1 #m. 
disruption of the osmotic stability of the cells (23,  28, 31). 
T. b.  brucei lysis may be a direct consequence of TLF bind- 
ing to the cell surface forming pores in the plasma mem- 
brane. Alternatively, lysis may require uptake and process- 
ing  of the  particles.  The  latter  case  is  supported  by  a 
20-40-rain delay observed in the onset of cell lysis following 
the addition of TLF to cells  (15, 29).  The availability of 
highly purified TLF made it possible to study binding and 
uptake of TLF by  T. b.  brucei and to discriminate between 
these possibilities. When trypanosomes were incubated with 
125I-TLF (2  /~g/ml)  at  4°C  binding  was  rapid  and  ap- 
proached equilibrium within 1 h (data not shown). The ex- 
tent of binding was a function of the extracellular concentra- 
tion of TLF (Fig.  2 A).  The shape of the binding curves 
suggests multiple binding components; a  high affinity/low 
capacity binding site which shows half-maximal binding at 
0.75  /zg/ml  and  a  low  affinity/high capacity  binding  site 
which fails to show saturable binding at concentrations of 
TLF as high as 30 #g/ml (Fig. 2 A). The lower concentration 
(0.75/zg/ml) is similar to the TLF concentration (0.66 #g/ml) 
required for in vitro lysis. This correlation suggests that the 
high-affinity binding  site  may mediate  killing.  From this 
Hager et al. HDL Lysis of Trypanosomes  159 Figure 5. Localization  of TLF-gold complexes in T. b. brucei at 37°C. Thin section electron microscopy  of  TLF-gold-treated  cells incubated 
at 4°C for 1 h, washed to remove any unbound TLF, and then shifted to 37°C for 1 h. (A) TLF-gold complexes are absent from the flagellar 
pocket (FP) and are now localized within large vesicles and free in the cytoplasm (arrow). (B, C) High magnification electron micrographs 
of serial sections though a large vesicle containing TLF-gold complexes (A). TLF-gold complexes released due to disruption of the vesicle 
membranes are seen (arrows). (D) TLF-gold complexes in a large vesicle containing electron dense material. The cell nucleus (N), Golgi 
(G), and other membrane bound organdies are intact. (E) High magnification electron micrograph of the TLF containing vesicle (D) 
reveals membrane disruption (arrows). (F) Section through a pair of cells containing TLF-gold complexes. (G, H) High magnification 
electron micrograph of the TLF-gold complexes reveals in F that the membranes of the vesicles are disrupted and localized cytoplasmic 
damage is seen. Bars: (A-C, E-H) 0.1  #m;  (D and E) 0.5 #m. 
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binding data, we calculate each trypanosome contains •350 
high affinity TLF binding  sites.  Non-lytic human  serum 
HDL  (p  =  1.063-1.17 g/ml)  also binds  rapidly  and in a 
saturable fashion to T. b. brucei when assayed under identi- 
cal conditions at 4°C.  The half-maximal binding for non- 
lyric HDL is 80/~g/ml with '~22,000 molecules per trypano- 
some (Fig. 2 B).  Taken together, these results suggest the 
presence of multiple binding sites on the trypanome surface 
for TLF and the lower binding sites might also bind non- 
lyric HDL. 
Since TLF and non-lyric HDL contain both apo A-I and 
apo A-U, it seemed likely that the low affinity TLF binding 
was to a general HDL binding site.  To test this possibility, 
we have carried out competition experiments with various li- 
poproteins. An excess of unlabeled TLF reduces TLF bind- 
ing to T. b. brucei by >90 %. Human LDL does not compete 
for ~25I-TLF  binding (<10% inhibition) and incubation with 
a 50-fold mass excess of purified VSG inhibited binding by 
<24 %. Thus nonspecific binding to VSG was a minor com- 
ponent in the binding studies. 
Non-lyric HDL, added at a 100-fold mass excess, reduced 
overall ~25I-TLF  binding by ~84% but had no effect on high 
affinity  binding (Fig. 2 C). Addition of 100-fold mass excess 
non-lyric HDL also had no effect on the lyric activity of TLF 
(Fig.  3).  By comparison, heat inactivated TLF (90°C,  15 
min) inhibited by thelyric activity of TLF up to 50 % (Fig. 
3). Adequate amounts of heat-inactivated TLF was not avail- 
able to test if lysis could be lowered further. 
TLF Binding Is Localized to the FlageUar Pocket 
To determine the localization of TLF-binding sites on intact 
trypanosomes, purified TLF was complexed with colloidal 
gold, and incubated at 4°C with trypanosomes (Fig. 4). The 
TLF-gold complexes appeared in negatively stained prepa- 
rations as a single 20-nm gold particle surrounded by 6-10 
lipoprotein particles (Fig. 4 A).  When trypanosomes were 
incubated with TLF-gold complexes, extensive binding to 
the flagellar pocket membrane (Fig. 4, B-D), and to a lesser 
extent to the flagellar membrane outside the pocket was seen 
(Fig. 4, D  and E).  TLF-gold complexes tend to associate 
with invaginations or pits along the flagellar pocket mem- 
brane (Fig. 4, B, C, F, and G). Association with membrane 
pits represents the initial stage in the endocytosis of TLE 
Since all binding and washing steps were carded out at low 
temperature,  presumably  no  internalization occurred.  To 
rule out nonspecific trapping of TLF-gold complexes in the 
flagellar pocket, colloidal gold alone (i.e., lacking TLF) was 
incubated with trypanosomes under identical conditions. No 
significant  binding to the cell surface or trapping of gold par- 
ticles within the flagellar pocket was seen (data not shown). 
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Figure 6. (A) Effect of temperature on the lysis of T. b. brucei by 
TLF. T. b. brucei was incubated for 2 h at 4,  10, 17, 20, 26, and 
37°C with 2 U (closed bars) and 8 U (open bars) of TLF added. 
The % lysis was determined as described in Material and Methods. 
(B) Effect of temperature on TLF localization. Thin section elec- 
tron microscopy of  TLF-gold-treated ceils incubated at 4°C for I h, 
washed to remove any unbound TLF, and then shifted to  17°C 
Endocytosis of TLF 
The uptake of gold conjugated TLF was examined by elec- 
tron microscopy. When trypanosomes were incubated with 
TLF-gold complexes at 4°C,  washed,  and then shifted to 
37°C for 1 h, gold-TLF particles were no longer restricted 
to the flagellar pocket. TLF-gold particles were seen within 
the cells, mainly localized in large, lysosome-like vesicles or 
free in the cytoplasm (Fig. 5, A-H). Redistribution of TLF 
to internal vesicles at 37°C  supports vesicle-mediated en- 
docytosis of TLE Surprisingly, the membranes of the large, 
TLF containing vesicles were disrupted and TLF-gold com- 
plexes were released into the cytoplasm (Fig.  5, A-H). 
TLF Lysis Involves a Temperature-sensitive Step 
Several aspects of TLF mediated lysis suggest a multi-step 
pathway toward cell death (Figs, 4 and 5). Earlier studies have 
shown that a lag period of at least 20 min precedes the lysis 
of T. b. brucei by TLF (29). This lag period can not be short- 
ened by raising the concentration of TLF (15).  Consistent 
with these observations, cells treated with native TLF for 15 
rain appear morphologically normal (reference 29; see also 
Fig. 7 C). It is also observed that lysis does not occur at 17°C 
regardless of the concentration of TLF (up to a 20-fold in- 
crease) or the time of TLF incubation (up to 6 h) (15).  At 
temperatures of 20  ° and 26°C, increasing the concentration 
of TLF (Fig. 6 A) or incubating the cells with TLF for longer 
than 2 h gradually increases TLF lysis. The "cold-sensitive" 
step (17°C  and below) in TLF-mediated lysis of trypano- 
somes might involve a membrane fusion event during the en- 
docytic pathway, analogous to the temperature sensitive step 
involving inhibition of endosome/lysosome fusion in higher 
eukaryotic cells  (9).  When trypanosomes were incubated 
with TLF-gold at 4°C for 1 h, washed to remove unbound 
TLF, and then incubated for an additional hour at 17°C (Fig. 
6, B  and C), TLF-gold complexes were seen in small vesi- 
cles and tubular structures in the cytoplasm near the flagellar 
pocket. As shown previously, at 37°C the TLF moves to LV 
which are then disrupted (Fig. 5). The relative occurrence 
of TLF-gold particles within the different cellular compart- 
ments or free in the cytoplasm at 4 °, 17  °, and 370C was deter- 
mined from electron micrographs (Figs. 4, 5, and 6, B and 
C) and was expressed as the relative frequency of TLF-gold 
particle distribution (Fig. 6 D). The redistribution of TLF 
to internal vesicles at elevated temperatures again supports 
the possibility that TLF binds the trypanosome surface and 
is taken-up into small vesicles by endocytosis and then trans- 
ferred to large vesicles (Figs.  4,  5,  A-J,  and 6;  see refer- 
ence 15). 
for 1 h. TLF-gold  complexes were found within the flageUar  pocket 
and a tubular network system (arrow)  near the flagella pocket. (C) 
Thin section electron micrograph of TLF-gold complexes in ceils 
incubated at 4°C, washed to remove unbound TLF, and shifted to 
17°C for 1 h. TLF-gold complexes are localized in the flageilar 
pocket (FP) and in small vesicles (arrows)  in the cytoplasm near 
the flageUar  pocket (FP). (D) Quanfitation of thin section electron 
microscopy results. Histogram  of the  distribution  of TLF-gold 
complexes at 4 °, 17  °, and 37°C. FP, flageUar  pocket; S~, small vesi- 
cles; LV, large vesicles. The relative frequency of TLF-gold distri- 
bution  is  shown for each  temperature.  Bars:  (B) 0.1  ~m;  (C) 
0.5 ~m. 
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Figure 8. Inhibition  ofTLF lysis by pH-raising agents. Lysis assays 
were carried out as previously described in Materials and Methods. 
(A) NI-L,C1 effects on lysis of T.  b.  brucei.  T.  b.  brucei was pre- 
treated  at 4°C  for 30  min with  1 to  32  mM NI-hC1 and then 
shifted to 37°C and incubated with ~2 U of TLF for 2 h. (B) Chlo- 
roquine effects on lysis of T. b. brucei.  T. b. brucei was pre-treated 
at 4°C for 30 rain with 0.25  to  100 #M chloroquine, and then 
shifted  to 37°C and incubated with ~2 U of TLF for 2 h.  (C) 
Monensin effects on lysis of T.  b.  brucei.  T.  b.  brucei was pre- 
treated at 4°C for 30 min with 0.01 to 0.1/~M monensin, and then 
shifted to 37°C and incubated with --2 U of TLF for 2 h. 
Figure 7. Loss of dextran staining upon exposure to native TLF at 
37°C. Phase contrast (left) and fluorescence  (right) microscopy  of 
bloodstream trypanosomes pre-loaded with 3 mg/ml rhodamine- 
labeled dextran 37°C 30' followed by mock or TLF treatment. The 
same bloodstream trypanosomes were  viewed by phase contrast 
(A-E) or fluorescence  (A-E). (A') Hoescht staining (of DNA) in 
mock treated  cells,  k, kinetoplast; n, nucleus (arrows).  (B') The 
bulk of dextran appears to have accumulated between the kineto- 
plast and nucleus (arrow). Other small vesicles are seen throughout 
the body. (C') Punctate fluorescence is maintained  in cells exposed 
to TLF for 15 min (arrows). (D') Punctate fluorescence  is lost in 
TLF exposed cells (37°C, 45'). (E') Cells exposed to TLF for 45 
min maintain  Hoescht staining. The kinetoplast and nucleus, how- 
ever, appear swollen (arrow). k, kinetoplast; n, nucleus. Bars: (A, 
B, and E) 4/~m; (C and D) 5/~m. 
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the activity and localization of TLE To examine the uptake 
and  localization  of  native  TLF,  a  bulk  phase  endocytic 
marker,  rhodamine-labeled  dextran,  was  incubated  with 
trypanosomes in the presence or absence of native TLF (Fig. 
7).  Fluorescence microscopy of trypanosomes incubated at 
37°C revealed accumulation of labeled dextran in small vesi- 
cles at several locations in the cytoplasm (Fig.  7  B'). The 
bulk  of  the  dextran  was  centrally  located  between  the 
Hoescht stained kinetoplast mitochondrial DNA (at the base 
of the flagellum) and the nucleus (Fig. 7 A'), consistent with 
lysosomal localization in trypanosomes (4,  5).  Co-incuba- 
tion of T. b. brucei for 45 min with TLF and dextran dramati- 
cally altered both the general morphology and distribution 
of rhodamine containing granules  (Fig.  7 D'). These cells 
lacked the crisp, punctate fluorescence seen in the absence 
of TLE Loss of vesicle staining coincided with an increase 
in overall cytoplasmic staining. Vesicle disruption appeared 
to precede loss of osmoregulation since some cells had lost 
vesicle staining but retained normal morphology (Fig. 7, D 
and D'). Vesicle disruption may be specific to the vesicles 
containing  rhodamine,  the  bulk phase  endocytic  marker, 
since both kinetoplast and nucleus,  although swollen, were 
intact as judged by Hoescht staining (Fig. 7 E') and electron 
microscopy (Fig. 5, B and F).  To determine if the fluores- 
cence observed above represented internalized material ver- 
sus  externally bound  material,  cells  were  incubated  with 
dextran alone at 4°C for 30 min. The cells were then washed 
and viewed under the microscope. No fluorescence was seen 
(data not shown). 
The Pathway of TLF-mediated Lysis Requires 
an Acidification Step 
Although the nature of the large vesicles can not be deter- 
mined directly from either electron or fluorescence micros- 
Figure 9. Inhibition of vesicle breakdown by pH-raising agents. Shown are fluorescence and light photomicrographs  of cells treated with 
the acidification inhibitors (as indicated) Am Chl,  Chor, and Mon in the absence (A, left, -TLF) or in the presence  (B, right, +TLF) 
of 2 U of TLE In each panel,  the left column shows the phase contrast microscopy of the trypanosomes  while the right column shows 
the fluorescence microscopy of the same cells. In each experiment,  the ceils were first incubated for 30 min at 4°C with the appropriate 
inhibitor, and then with 3 mg/ml dextran for 30 min at 37°C, and then  +  TLF for 45 min at 37°C. Inhibitor concentrations were NI-hCI 
(Am CI) =  8 raM; chloroquine (Chor) =  50 gM; Monensin (Mon) =  0.1 #M. (Note: All micrographs are same magnification with the 
exception of Monensin-treated  cells).  Bars,  5 #m. 
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Figure 11. Proposed model for TLF-mediated lysis in Z  b. brucei. 
The lyric pathway can be blocked at several steps:  (a) anti-TLF 
blocks binding to the flageilar pocket (FP) binding site;  (b) 4°C 
binding occurs within the flagellar pocket but endocytosis does not 
occur; (c) at 17°C endocytosis occurs but TLF does not move from 
small coated vesicles (CV); or (d) treatment with ammonium chlo- 
ride blocks the acidification of endosomes or lysosomes and blocks 
cell lysis at 37°C. At 37°C, after a lag of '~ 30 min, lysis occurs, 
and is correlated with the breakdown of vesicle membranes.  VSG, 
variable surface glycoprotein; F, flagellum; C/', coated pit. 
Figure 10.  Requirement for a thioprotease is implicated.  (A) Leu- 
peptin effects on the lysis of T. b. brucei.  T. b. brucei was pre-treated 
with 0.01 to 1.0 mM leupeptin for 1 h at 37°C. Cells were then incu- 
bated with ~2 U of TLF for an additional 2 h at 370C. (B-C) Cells 
were incubated with 0.6 mM leupeptin (B). Phase contrast of ceils 
mock treated with buffer instead of TLE (B') Fluorescence  of the 
cells in B. (C) Phase contrast of cells treated with TLE (C') Fluo- 
rescence of the ceils in C. Bar, 5/~m. 
copy (Figs. 5 and 7) their size, morphology, and intracellular 
location are highly suggestive of lysosomes. One hallmark 
of the lysosome is that it is an acidic compartment. To deter- 
mine whether TLF passes through an acidic compartment 
following endocytosis by trypanosomes, and whether acidi- 
fication is necessary for TLF-mediated lysis, we examined 
the effect of pH-elevating agents on TLF activity (Fig. 8; ref- 
erence 34). Incubation of trypanosomes with i>8 mM ammo- 
nium chloride inhibited TLF lysis by >83 % (Fig. 8 A). Chlo- 
roquine, another lysosomotropic amine, at concentrations of 
I>50/~M inhibited lysis by 98%  (Fig.  8 B).  The ionophore 
monensin,  at  a  concentration  of 0.1  /zM,  inhibited  TLF- 
mediated lysis by >80% (Fig. 8 C). The inhibitor concentra- 
tions used above were not lethal to the trypanosomes how- 
ever,  high  concentrations  of these  inhibitors  are  toxic  to 
them (see Materials and Methods).  These findings indicate 
that TLF requires an acidic environment to become active. 
These studies suggested to us that prevention of acidifica- 
tion might also prevent TLF-mediated disruption of the dex- 
tran-loaded vesicles as seen in Fig. 7 C. We tested this idea 
using the same lysosomotropic amines as above in conjunc- 
tion with fluorescence microscopy (Fig. 9). In the presence 
of the lysosomal inhibitors, dextran accumulated in the large 
vesicles (Fig.  9,  -TLF).  Thus, these agents do not block 
endocytic uptake.  Upon exposure to TLF for 45  min, the 
cells pre-treated with chloroquine, ammonium chloride, or 
monensin maintained punctate fluorescence in the perinuclear 
region of the cell (Fig. 9,  + TLF). This is in striking contrast 
to the breakdown of fluorescent vesicles seen in TLF-treated 
cells not pre-treated with lysosomal inhibitors (Fig. 7 D'). 
Thioproteases Implicated in TLF Lyric Mechanism 
What is the mechanism of cell lysis? Since TLF appears to 
Hager et al. HDL Lysis of Trypanosomes  165 localize to the lysosome and membrane disruption precedes 
cell death, cell lysis might be a consequence of the release 
of lysosomal hydrolases into the cytoplasm. These enzymes 
would  then  lead  to  cell  lysis by  actively degrading  the 
cytoplasm of the trypanosome. Inhibition of some of the 
hydrolases might make TLF less toxic to the cell. Alterna- 
tively,  lysosomal proteases  might be  directly involved in 
vesicle disruption and subsequent cell lysis. To test these 
possibilities,  we  incubated trypanosomes with leupeptin, 
a thioprotease inhibitor. Cells were pre-incubated with leu- 
peptin then treated with TLF for 2  h  at 37°C.  Leupeptin 
inhibited TLF  lysis by  *60%  at  0.8  mM  (Fig.  10  A). 
Fluorescence studies were carded out to determine whether 
TLF-mediated disruption of  the dextran-labeled vesicles was 
also inhibited by leupeptin (Fig.  10, B and C). Control ex- 
periments with cells treated with leupeptin alone indicated 
that it does not block endocytosis of rhodamine dextran (Fig. 
10, B and/7). To examine the effects of the inhibitor on TLF 
action, cells were pre-treated with leupeptin and dextran be- 
fore incubation with TLF at 37°C for 45 rain.  Leupeptin 
blocked TLF-induced breakdown of the rhodamine-labeled 
endocytic vesicles (Fig. 10 C). Higher concentrations (>11.0 
mM) of leupeptin were toxic to the ceils raising background 
lysis (inhibitor alone) to >20%. These results suggest thio- 
proteases are involved in the action of TLF. 
Discussion 
The purification of TLF from human serum has enabled us 
to study the interaction of  this minor subclass of  human HDL 
with trypanosomes. In agreement with the studies of Gillett 
and Owen (12),  we find that human HDL binds to  T.  b. 
brucei in a rapid and saturable fashion. Binding studies with 
purified TLF indicate there are sites on the trypanosome sur- 
face that can bind TLF (Fig. 2).  These sites are proteins 
since trypsin treatment (3)  abolishes  I:SI-TLF binding by 
>65 %  (Hager,  K.  M., unpublished data).  One site binds 
non-lyric HDL  (p  =  1.063-1.17  g/ml)  and  is  present  at 
~22,000 molecules per cell. A second, higher affinity site, 
present  at  about  350  molecules  per  cell,  appears  to  be 
specific for TLF since this binding was not inhibited by high 
concentrations of non-lyric HDL (Fig. 2).  Consistent with 
the inability of non-lyric HDL to completely block TLF 
binding, we find non-lyric HDL does not compete for lysis 
while heat inactivated TLF does (Fig. 3). Since TLF repre- 
sents a minor subclass of human HDL, comprising <1% of 
the total serum HDL, it is likely that the binding of TLF in 
intact serum is mediated by this TLF-specific binding site. 
Further, binding occurs exclusively in the flagellar pocket 
and to the flagellum (Fig. 4).  These results are consistent 
with LDL and transferrin studies on receptor-mediated en- 
docytosis in trypanosomes which suggest that trypanosome 
receptors are located on the flagellar membrane and flagellar 
pocket membrane (2, 6, 7, 21, 26, 33). 
After binding, TLF is internalized by T. b. brucei. This is 
the first evidence that TLF is taken-up by trypanosomes be- 
fore cell lysis (Figs. 5 and 6).  Electron micrographs show 
that at 37°C, cytoplasmic vesicles are disrupted prior to cell 
lysis. The vesicles are large and lysosome-like. Fluorescent 
microscopy shows native TLF disrupted endocytic vesicles 
after a lag period of 20 min. It is intriguing that cells show 
vesicle disruption after being exposed to TLF for 45 rain 
even though they have not yet exhibited a loss in osmoregula- 
tion. It is likely that these cells represent the step between 
vesicle disruption and the loss of osmoregulation that ulti- 
mately leads to cell death. 
Studies in mammalian systems have previously shown that 
endosomal fusion with the lysosome is blocked at 17°C (9). 
When trypanosomes are  incubated at  17°C,  gold-labeled 
TLF is observed within small endocytic vesicles or tubules 
contiguous with the flagellar pocket. A temperature of 17°C 
is a nonpermissive temperature for TLF lysis, despite TLF's 
internalization to endosomes. At 37°C, a permissive temper- 
ature for TLF-mediated lysis, TLF is seen in large lyso- 
some-like structures. The preservation of  the integrity of  this 
large lysosome-like compartment is intimately linked with 
the maintenance of osmoregulation. Taken together, these 
temperature studies indicate that TLF not only has to be in- 
ternalized but also implicates a lysosomal compartment. 
Our inhibitor studies with the pH-raising agents (34) fur- 
ther implicated a  lysosomal compartment.  They revealed 
that TLF must pass through an acidic compartment in order 
to disrupt endocytic vesicles and be cytotoxic to trypano- 
somes (Figs. 8 and 9). Since TLF appears to be capable of 
disrupting internal membrane compartments, why is TLF 
not active on the plasma membrane of the trypanosome? 
TLF might be inactive outside of the trypanosome and acti- 
vated only when internalized. Activation might be due either 
to modification of a TLF component (protein or lipid) or al- 
teration of its environment (pH or salt concentration). It is 
likely to be affected if it is within the acid protease rich envi- 
ronment of the lysosome. Further, it is higkly probable that 
the disruption of lysosomal membranes by TLF and the sub- 
sequent release of their hydrolases would lead to cell death 
by autodigestion (Fig.  11). 
The actual mechanism of lysosomal disruption by TLF re- 
mains a mystery. However,  the leupeptin inhibitor studies 
shed some light on the process. When cells are pre-incubated 
with leupeptin,  cells are  spared  TLF-mediated lysis and 
TLF-mediated vesicle disruption is inhibited. It is possible 
TLF requires a thioprotease-mediated activation step.  It is 
important to recall TLF has two unique apolipoproteins, L-I 
and L-Ill, that exist as disulfide-linked oligomers (15). Per- 
haps these apolipoproteins require processing to a  "toxic" 
form in order to act on membranes. Future in vitro experi- 
ments will address the mechanism of vesicle breakdown and 
better define the "activation" process. A number of specific 
enzymes have been found associated with serum HDLs, in- 
cluding both proteases and lipases (20).  It is tempting to 
speculate that one of the unique components of TLF (either 
apo L-I and/or apo L-III) might be capable of disrupting in- 
tracellular membranes upon  activation following endocy- 
tosis. 
We propose the following pathway for TLF mediated lysis 
(Fig.  11). TLF binds  specifically to  sites  in the flagellar 
pocket of the trypanosome. TLF binding can be blocked by 
the action of  monoclonal antibodies against the TLF-specific 
apolipoproteins apo L-I and apo L-l]/. Binding is followed 
by endocytosis and delivery of the endocytosed molecules to 
a lysosomal compartment. Finally, TLF disrupts lysosomal 
membranes causing release of the contents into the cyto- 
plasm.  Thus, the primary site of TLF action is inside the 
trypanosome and the previously observed osmotic instability 
of the trypanosomes (29, 30) is a late event in the lyric path- 
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mechanism. As a natural killing factor, TLF is unique in that 
it not only requires internalization but also a putative activa- 
tion step. 
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